Live Chat
Live Chat

About Us

Share

Share

Scientific Advisory Board

Steven DeKosky, M.D.

Steven DeKosky, M.D.

Member, RiverMend Health Scientific Advisory Board

Dean, Vice President & Professor of Neurology, School of Medicine, University of Virginia

My Clinical Expertise:

  • Neurology
  • Dementia & Alzheimer’s Disease
  • Bioethics
  • Traumatic Brain Injury

Dr. DeKosky is currently on sabbatical at the University of Pennsylvania studying Bioethics. He is Professor of Neurology and Director of the Alzheimer’s Disease Center at the University of Virginia. From 2008 to 2013 he was the James Carroll Flippin Professor of Medical Science, and Vice President and Dean of the University of Virginia School of Medicine.

From 2000 to 2008 he was Professor and Chair of the Department of Neurology at the University of Pittsburgh. Dr. DeKosky was Director of the Pitt’s NIH-funded Alzheimer’s Disease Research Center (ADRC) from 1994-2008. His basic research focuses on structural and neurochemical changes in the aging human brain as well as dementia and effects of traumatic brain injury. His clinical research is centered on understanding the genetics, neuropsychiatric symptoms, neuroimaging, and treatment and prevention of AD. He was a Principal Investigator in the clinical application of the breakthrough amyloid-imaging agent Pittsburgh Compound B (PiB). Dr. DeKosky was a member of the national Board of Directors of the Alzheimer’s Association from 1994 to 2002 (Board Vice Chair in 2001-2002), and again from 2003 to 2010.

He directed an NIH-funded national multicenter trial to assess whether ginkgo biloba can prevent or delay onset of dementia in normal elderly adults.

Dr. DeKosky has served as Chair of the Section on Geriatrics of the American Academy of Neurology (AAN), and chaired the AAN Practice Parameters Committee for Early Detection, Diagnosis and Management of Dementia. Dr. DeKosky has received the Rita Hayworth Award from the Alzheimer’s Association and the Ronald and Nancy Reagan Research Institute Award for his contributions to research and advocacy on behalf of people with Alzheimer’s disease and their families. He has received a Teacher Investigator Development Award from the NINDS, the Presidential Award of the American Neurological Association, and is listed in "The Best Doctors in America" and “America’s Top Doctors.” He has published over 400 peer-reviewed articles and book chapters.

  • James Carroll Flippin Professor of Medical Science, 2008-2013
  • Vice President and Dean of the University of Virginia School of Medicine
  • Chair, Section on Geriatrics of the American Academy of Neurology (AAN)
  • Chair, AAN Practice Parameters Committee for Early Detection, Diagnosis and Management of Dementia
  • Professor and Chair of the Department of Neurology at the University of Pittsburgh
  • Director of the Pitt’s NIH-funded Alzheimer’s Disease Research Center
  • Principal Investigator in the clinical application of the breakthrough amyloid-imaging agent Pittsburgh Compound B (PiB)
  • Member of the National Board of Directors of the Alzheimer’s Association
  • Directed an NIH-funded national multicenter trial to assess whether ginkgo biloba can prevent or delay onset of dementia in normal elderly adults
  • Recipient, Rita Hayworth Award from the Alzheimer’s Association and the Ronald and Nancy Reagan Research Institute Award, Teacher Investigator Development Award from the NINDS, and the Presidential Award of the American Neurological Association
  • Listed in "The Best Doctors in America" and “America’s Top Doctors”
  • Published over 400 peer-reviewed articles and book chapters

Coming Soon

Coming Soon